Cytovance Biologics Selects Sartorius BBI Systems GmbH Bioreactors For Oklahoma City Biopharmaceutical Manufacturing Facility

Published: Nov 22, 2005

OKLAHOMA CITY--(BUSINESS WIRE)--Nov. 22, 2005--Cytovance Biologics announced today that it has selected Sartorius BBI Systems Inc., a leading designer and manufacturer of bioprocess equipment and automation systems, to supply bioreactors for its cGMP biopharmaceutical production facility in Oklahoma City, Okla.

Back to news